BPIL3 Activators
BPIL3 Activators are a class of compounds that, while not directly interacting with BPIL3, elicit cellular responses that can lead to the enhanced activity of BPIL3. These activators function by stimulating various pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), which play key roles in the innate immune system's response to pathogens. For instance, lipopolysaccharide (LPS) and monophosphoryl lipid A (MPLA), both TLR4 agonists, can enhance BPIL3 activity by promoting an inflammatory milieu conducive to the activation of BPIL3's bactericidal functions. Similarly, muramyl dipeptide (MDP), through NOD2 activation, and polyinosinic-polycytidylic acid (Poly(I:C)), through TLR3 activation, lead to the production of type I interferons and other cytokines that can augment BPIL3 activity.
Moreover, compounds such as CpG oligodeoxynucleotide and flagellin, which activate TLR9 and TLR5 respectively, induce a strong Th1 immune response and NF-κB-mediated transcription of immune-related genes, including those that could be associated with BPIL3. The activation of the immune system by these compounds results in a cascade of signaling events that can increase the expression or functional activity of BPIL3. For example, synthetic lipopeptides like Pam3CSK4 and FSL-1, which are TLR2/TLR6 agonists, and imidazoquinoline compounds such as imiquimod and resiquimod, which are TLR7 and TLR8 agonists, stimulate cytokine production and inflammatory responses that can indirectly enhance the activity of BPIL3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
Lipopolysaccharide (LPS) is a component of the outer membrane of Gram-negative bacteria. It can activate immune cells by binding to TLR4, leading to NF-κB activation. NF-κB translocation can enhance BPIL3 activity by upregulating pro-inflammatory cytokines and effector molecules that BPIL3 may interact with or respond to. | ||||||
Polyinosinic-polycytidylic acid potassium salt | 31852-29-6 | sc-202767 | 5 mg | $198.00 | ||
Poly(I:C) mimics viral double-stranded RNA, activating TLR3 and inducing type I interferon responses. This can enhance BPIL3 activity by upregulating immune responses that BPIL3 is part of, particularly in antiviral defense where its activity may be crucial. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod is a synthetic imidazoquinoline and an agonist of TLR7. It induces the secretion of pro-inflammatory cytokines and enhances innate immune responses. This can indirectly enhance BPIL3 activity by activating immune responses where BPIL3 may play a role, especially in antiviral defense mechanisms. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
Resiquimod is another imidazoquinoline that activates TLR7 and TLR8. It induces cytokine production and enhances immune responses. Resiquimod can enhance BPIL3 activity by activating signaling pathways that upregulate the expression of proteins associated with innate immunity, including BPIL3. | ||||||
Zymosan | 9010-72-4 | sc-296863 sc-296863A | 100 mg 1 g | $99.00 $599.00 | 1 | |
Zymosan is a polysaccharide from yeast cell walls and activates TLR2/TLR6. It triggers pro-inflammatory signaling leading to cytokine production. Zymosan can enhance BPIL3 activity as part of the innate immune response to fungal pathogens, possibly increasing the expression or activity of BPIL3. | ||||||
Pam3Cys-Ser-(Lys)4 trihydrochloride | 112208-04-5 | sc-202271 | 2 mg | $431.00 | ||
Pam3CSK4 is a synthetic triacylated lipopeptide that mimics the acylated amino termini of bacterial lipoproteins, activating TLR1/TLR2. It can enhance BPIL3 activity by inducing cytokine production and inflammatory responses, possibly increasing BPIL3's role in bacterial defense. | ||||||